D89.834
Cytokine release syndrome, grade 4
Clinical Classification Guidelines
Medical Intelligence & Overview
Cytokine Release Syndrome (CRS) is a serious and potentially life-threatening condition characterized by a large, rapid release of cytokines into the bloodstream. Cytokines are proteins that regulate immune responses and inflammation. When these are released in excess, they can cause systemic symptoms and organ dysfunction. Grade 4 CRS represents the most severe level of this syndrome, requiring urgent medical attention and aggressive treatment. This condition is commonly associated with certain immunotherapies, such as CAR T-cell therapy, but can also arise in other contexts involving immune system activation.
Causes & Symptoms
Clinical Causes: Immunotherapy treatments, particularly chimeric antigen receptor (CAR) T-cell therapy Certain infections leading to immune overactivation Some bone marrow or stem cell transplants Other immune-modulating therapies that stimulate cytokine production
Key Symptoms: High fever and chills Difficulty breathing or shortness of breath Low blood pressure (hypotension) Swelling in the limbs, face, or other areas Severe fatigue and weakness Nausea, vomiting, or diarrhea Altered mental status, confusion, or agitation Organ dysfunction, including liver, kidney, or heart problems Skin redness or rash
Diagnostic & Treatment
Diagnosis Path: Diagnosis of grade 4 CRS involves a combination of clinical assessment and laboratory tests. Medical professionals evaluate symptoms such as high fever, low blood pressure, rapid breathing, and mental state changes. Blood tests are used to measure inflammatory markers, cytokine levels, and organ function indicators. Imaging studies may be employed to assess organ health. The severity is classified based on established grading criteria, with grade 4 indicating life-threatening features requiring immediate intervention.
Treatment Protocols: Administration of supportive therapies such as intravenous fluids and medications to stabilize blood pressure Use of corticosteroids to reduce inflammation and cytokine levels Administration of cytokine-blocking agents, such as tocilizumab, an IL-6 receptor antagonist Oxygen therapy or mechanical ventilation if breathing is compromised Continuous monitoring of vital signs and organ functions in an intensive care setting Additional interventions might include medications to support kidney or liver function if affected
Clinical Advice & FAQs
Billing Guidance
Is D89.834 a billable ICD-10 code?
Yes, D89.834 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.834?
Clinical documentation must specify the nature of Cytokine release syndrome, grade 4 and any associated comorbidities for accurate reporting.
Cite this Clinical Reference